| abstract |
The novel sulfonamidocarboxamides of formula (I) below and their hydrates or solvates inhibit thrombin-induced blood platelet aggregation and coagulation of fibrinogen in plasma. This compound is prepared by amidation of the cyclic amino group represented by group X or formation of C (O) N (Q) amide.n n n n n n n n In the above formula, A, M, Q, X and Y are as defined in the specification. |